Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3091 of 6351
-
New electrode design may extend pain relief for common back condition
Symptom relief Recruiting nowSpondylosis is an anatomical defect of the small facet joints between the spinal vertebrae often due to load bearing and mechanical wear. It is a major contributor to lower back pain. The current standard of care in patients diagnosed with spondylosis in the lower back is to perf…
Sponsor: University of Arkansas • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Loneliness therapy may curb opioid misuse in pain patients
Disease control CompletedLoneliness, which is the perceived feeling of insufficient personal relationships, is related to higher risk for inappropriate opioid use and opioid use disorders in patients who are taking opioids long-term. The study seeks to pilot test the evidence-based loneliness interventio…
Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
No more fear of the dentist? new VR treatment shows promise
Symptom relief OngoingThe purpose of this study is to compare an intervention for dental fear to the usual approach (i.e., whatever your dentist typically does to help you manage fear) in reducing patient fear and making dentist appointments more tolerable. The dental fear intervention (called neVR Fe…
Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New lupus pill enters human testing
Disease control Recruiting nowTo evaluate the safety, tolerability, pharmacokinetics and pharmacokinetics of multi-dose APG-2575 in mild-to-moderate systemic lupus erythematosus (SLE).
Phase 1/2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a 6-Week zoom therapy help kids at risk for depression? st. louis schools test new approach
Symptom relief By invitation onlyThis study is designed to test the effectiveness and implementation of an early intervention therapy for children and their primary caregivers by using existing school counselors across several school districts. The intervention is a 6-8 week caregiver-child intervention (THRIVE…
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Hospital navigator program aims to close gaps in opioid treatment access
Knowledge-focused CompletedPatient Navigation (PN) interventions following hospitalization can reduce the differences that certain groups have been trying to access opioid use disorder treatment. These differences, which affect racial minority groups the most, contribute to the opioid overdose epidemic. Ho…
Sponsor: Friends Research Institute, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Online diet program shows promise for fatty liver
Disease control OngoingStudy Summary Title: Mediterranean Diet Intervention for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Randomized Controlled Trial (The TIMA Study) Introduction: This trial, known as the TIMA (Taiwanese Mediterranean dietary intervention for MASLD) study, …
Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can talking therapy stop weight regain after surgery?
Disease control Recruiting nowThe goal of this clinical trial is to learn if a psychological intervention can increase regular physical activity to help prevent weight regain after metabolic bariatric surgery in adults. The main questions it aims to answer are: 1. Does the psychological intervention increase…
Sponsor: Hartford Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug IASO-782 aims to tame immune attacks on blood cells
Disease control Recruiting nowThis study is a randomized, double-blinded, and placebo-controlled phase Ia clinical study in subjects with autoimmune hematological diseases. The study is designed to assess the safety and tolerability of IASO-782 for the treatment of autoimmune haematological diseases (ITP and …
Phase 1 • Sponsor: Shanghai IASO Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can better outreach fix hypertension gaps? UCLA launches large study
Disease control OngoingThe goal of the study is to promote equitable hypertension (HTN) management across the diverse patient population found in Los Angeles County Department of Health Services (LAC DHS) clinics. To achieve this goal, the study team will conduct provider- and patient-focused outreach…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Scientists deliberately infect volunteers with omicron to study the virus
Knowledge-focused OngoingA phase 1, dose-finding open label clinical infection, safety and viral detection optimization in healthy volunteers immunologically experienced against SARS-CoV-2.
Phase 1 • Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Collagen pills promise younger skin – but do they deliver?
Symptom relief CompletedThe goal of this clinical trial is to evaluate whether daily oral supplementation with 2.5 g of specific bioactive collagen peptides (SCP) can improve skin physiology in healthy adult women aged 35-55 years. The main questions it aims to answer are: Does SCP supplementation incr…
Sponsor: Collagen Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New weekly shot aims to tackle obesity and diabetes
Disease control CompletedA new study medicine called NNC0519-0130 to improve treatment options for people living with excess body weight, with or without type 2 diabetes. The purpose of the study is to investigate potential side effects and blood levels of NNC0519-0130, as well as changes in body weight,…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Beetroot juice boosts exercise in lung disease patients?
Symptom relief Recruiting nowExercise training as part of a structured pulmonary rehabilitation program is a key factor in improving quality of life and symptoms in people with interstitial lung disease (ILD). Optimal methods of exercise training are yet to be explored in ILD. Drinking beetroot juice, which …
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Could probiotics be a new way to help kids with autism?
Symptom relief Recruiting nowIn this trial, the investigators aim to evaluate the impact of a multispecies probiotic consisting of Bacillus subtilis W201, Bifidobacterium infantis W17, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus rhamnosus W140, Lactococc…
Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Real-World hair loss drug study launches: will ritlecitinib deliver in practice?
Disease control OngoingAlopecia areata (AA) is a chronic relapsing autoimmune disease characterized by nonscarring hair loss affecting children, adolescents, and adults across all ages, races, and genders. AA primarily affects the scalp; however, it also can affect nails, eyelashes, eyebrows, and other…
Sponsor: Pfizer • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
New painkiller nalbuphine takes on morphine in Post-Surgery trial
Symptom relief CompletedEvaluation of safety and efficacy of Nalbuphine versus Morphine patient controlled intravenous analgesia (PCIA) for the treatment of postoperative analgesia
Phase 3 • Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Cholesterol drug paired with immunotherapy shows promise for tough kidney cancer
Disease control OngoingTo learn if evolocumab and nivolumab can control metastatic and refractory renal cell carcinoma. The safety of this drug combination will also be studied.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New shot aims to stop stomach bug that sickens millions
Vaccine CompletedThis is a study of CDC-9 inactivated rotavirus vaccine (IRV) for intramuscular administration (IM) in healthy adults aged 18 to 45 years at two dose levels in a 3-dose series. The purpose is to determine if it is safe and if the recipient's immune system responds to the vaccine.
Phase 1 • Sponsor: Centers for Disease Control and Prevention • Aim: Vaccine
Last updated Jun 27, 2026 12:37 UTC
-
Brain training boosts thinking skills in schizophrenia
Symptom relief Recruiting nowAdults with serious mental illnesses (such as schizophrenia and schizoaffective disorders) often experience a range of cognitive difficulties (such as memory, problem solving difficulties) that affect their ability to lead meaningful life roles. Cognitive remediation is an interv…
Sponsor: Singapore Institute of Technology • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC